![Michael Courtney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Courtney served as Chairman & CEO of Aptanomics SA in 2008, President & CEO of Imaxio SA, and President of CellVir SAS. He received an undergraduate degree from the University of Glasgow and a doctorate degree from the University of London.
| Companies | Position | End |
|---|---|---|
CellVir SAS
 CellVir SAS Pharmaceuticals: OtherHealth Technology Develops anti-retrovirals based on novel therapeutics | Chairman | 03/06/2012 |
Aptanomics SA
 Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Chairman | 23/01/2008 |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Develops biopharmaceutical products | Chairman | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Imaxio SA
Imaxio SA Medical SpecialtiesHealth Technology Develops biopharmaceutical products | Health Technology |
CellVir SAS
CellVir SAS Pharmaceuticals: OtherHealth Technology Develops anti-retrovirals based on novel therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
